Total Payments
$2,698
2024 Payments
$332.91
Companies
28
Transactions
140
Medicare Patients
2,618
Medicare Billing
$296,224
Payment Breakdown by Category
Food & Beverage$2,662 (98.7%)
Gifts$35.76 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,662 | 139 | 98.7% |
| Gift | $35.76 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $653.22 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $338.26 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $314.71 | 20 | $0 (2024) |
| Gilead Sciences, Inc. | $155.05 | 3 | $0 (2024) |
| PFIZER INC. | $145.67 | 10 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $97.65 | 7 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $85.16 | 4 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $84.41 | 5 | $0 (2018) |
| Medtronic Vascular, Inc. | $79.99 | 1 | $0 (2018) |
| INTERCEPT PHARMACEUTICALS, INC. | $79.88 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.91 | 6 | Gilead Sciences, Inc. ($139.89) |
| 2023 | $193.23 | 11 | AbbVie Inc. ($68.27) |
| 2022 | $191.41 | 10 | ABBVIE INC. ($87.57) |
| 2021 | $332.98 | 16 | AbbVie Inc. ($135.21) |
| 2020 | $447.84 | 25 | AbbVie Inc. ($114.67) |
| 2019 | $529.18 | 29 | PFIZER INC. ($118.96) |
| 2018 | $349.59 | 20 | Medtronic Vascular, Inc. ($79.99) |
| 2017 | $321.10 | 23 | AbbVie, Inc. ($46.95) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: IMMUNOLOGY | ||||||
| 02/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Gastroenterology | ||||||
| 02/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/06/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.41 | General |
| Category: HCV | ||||||
| 01/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.48 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/29/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/09/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: GI | ||||||
| 10/11/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: VIROLOGY | ||||||
| 06/27/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: GI | ||||||
| 06/08/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/11/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.16 | General |
| 04/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Neuroscience | ||||||
| 03/07/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: VIROLOGY | ||||||
| 02/16/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/17/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Gastroenterology | ||||||
| 08/22/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/23/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/16/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Rare Disease | ||||||
| 05/05/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 510 | 574 | $233,157 | $64,856 |
| 2022 | 13 | 564 | 637 | $216,247 | $66,220 |
| 2021 | 12 | 767 | 855 | $240,654 | $87,878 |
| 2020 | 15 | 777 | 874 | $253,436 | $77,270 |
Total Patients
2,618
Total Services
2,940
Medicare Billing
$296,224
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 87 | 88 | $61,420 | $17,072 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 144 | $29,086 | $14,117 | 48.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 96 | 103 | $59,946 | $7,864 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $14,271 | $6,554 | 45.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 41 | $18,630 | $5,535 | 29.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 44 | 47 | $20,821 | $3,840 | 18.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $14,796 | $3,426 | 23.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,648 | $1,984 | 54.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $5,698 | $1,928 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 24 | $2,816 | $1,525 | 54.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 15 | $2,025 | $1,011 | 49.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 64 | 65 | $34,830 | $11,739 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 111 | $21,978 | $10,602 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $20,817 | $9,916 | 47.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 95 | 103 | $64,132 | $7,885 | 12.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $12,596 | $5,198 | 41.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $19,180 | $4,550 | 23.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 42 | $8,568 | $4,408 | 51.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 72 | $7,776 | $4,003 | 51.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 31 | 32 | $15,552 | $2,705 | 17.4% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $4,728 | $2,505 | 53.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 13 | $2,574 | $1,219 | 47.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 18 | $2,513 | $965.47 | 38.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 17 | $1,003 | $524.35 | 52.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 163 | $30,738 | $16,724 | 54.4% |
About Dr. Paula Dionisio, M.D
Dr. Paula Dionisio, M.D is a Gastroenterology healthcare provider based in Pueblo, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669457263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paula Dionisio, M.D has received a total of $2,698 in payments from pharmaceutical and medical device companies, with $332.91 received in 2024. These payments were reported across 140 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,662).
As a Medicare-enrolled provider, Dionisio has provided services to 2,618 Medicare beneficiaries, totaling 2,940 services with total Medicare billing of $296,224. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Pueblo, CO
- Active Since 12/07/2005
- Last Updated 02/17/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1669457263
Products in Payments
- HUMIRA (Biological) $256.41
- XIFAXAN (Drug) $198.42
- XELJANZ (Drug) $131.78
- TRULANCE (Drug) $127.12
- Epclusa (Drug) $124.41
- SKYRIZI (Biological) $122.09
- LINZESS (Drug) $109.62
- ENTYVIO (Biological) $103.34
- Entyvio (Biological) $96.43
- ZENPEP (Drug) $85.16
- Trulance (Drug) $84.41
- VenaSeal (Device) $79.99
- STELARA (Biological) $78.86
- Humira (Biological) $76.94
- CREON (Drug) $63.37
- DIFICID (Drug) $54.41
- Mulpleta (Drug) $50.58
- OCALIVA (Drug) $48.73
- Linzess (Drug) $45.26
- XERAVA (Drug) $41.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Pueblo
Mr. Charles Ruzkowski, Md, MD
Gastroenterology — Payments: $5,914
Gastroenterology $5,914
Dr. Sung Yang, M.d, M.D
Gastroenterology — Payments: $5,539
Gastroenterology $5,539
Lirio Polintan, Md, MD
Gastroenterology — Payments: $2,146
Gastroenterology $2,146
Mena Tawfik, Md, MD
Gastroenterology — Payments: $1,345
Gastroenterology $1,345
Dr. Henrique Fernandez, Md, MD
Gastroenterology — Payments: $1,211
Gastroenterology $1,211
Maritza Proano, M.d, M.D
Gastroenterology — Payments: $110.51
Gastroenterology $110.51